Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05590377 |
|---|---|
| Brief Title: | A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma (iinnovate-3) |
| First Submitted : | October 19, 2022 |
| First Submitted that Met QC Criteria : | October 19, 2022 |
| First Posted : | October 21, 2022 |
| Last Update Submitted that Met QC Criteria : | April 2, 2024 |
| Last Update Posted : | April 3, 2024 |